Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study.

Tsai-Sheng Yang,Hong-Hwa Chen,Lin Bo-Wen,Tae Won Kim,Jong Gwang Kim,Joong Bae Ahn,Myung-Ah Lee,Johnson Lin,Gwo Fuang Ho,Le Tuan Anh,Sally Temraz,Matthew Burge,Clarinda Chua,Jason Huang,Young Suk Park

Asia-Pacific journal of clinical oncology（2023）

引用 0|浏览38

暂无评分

摘要

Cetuximab-based 5-FU regimens were effective first-line treatments for mCRC in routine practice, particularly in patients with left-sided disease and liver metastases only.

查看译文

关键词

5-fluorouracil,cetuximab,first-line,metastatic colorectal cancer,observational study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要